SCHEMBL1013870

SCHEMBL1013870

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(OCc2ccco2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
HPGD P15428 4/20 0.45
MAPT P10636 4/20 0.45
RXFP1 Q9HBX9 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
SERPINE1 P05121 1/20 0.45
TP53 P04637 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
POLB P06746 4/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
GAA P10253 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 3/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016303 0.91 SERPINE1 (0.55) ALDH1A1HPGDMAPTRXFP1NPSR1
SCHEMBL1015206 0.87 KDM4E (0.47) ALDH1A1HPGDMAPTRXFP1NPSR1
SCHEMBL1016295 0.83 LCLAT1 (0.49) ALDH1A1HPGDMAPTSERPINE1SMN1; SMN2
SCHEMBL1015672 0.79 ALDH1A1 (0.58) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL1018800 0.79 GRIK1 (0.47) ALDH1A1HPGDMAPTRXFP1NPSR1
SCHEMBL417150 0.79 SERPINE1 (0.60) ALDH1A1HPGDMAPTNPSR1SERPINE1
SCHEMBL1013840 0.78 SERPINE1 (0.55) ALDH1A1HPGDMAPTRXFP1NPSR1
SCHEMBL1015662 0.77 SERPINE1 (0.64) ALDH1A1MAPTNPSR1SERPINE1SMN1; SMN2
SCHEMBL1797516 0.77 ALDH1A1 (0.50) ALDH1A1HPGDMAPTRXFP1SMN1; SMN2
SCHEMBL1015837 0.77 CNR1 (0.51) ALDH1A1MAPTSERPINE1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885HPGD 683/4885MAPT 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.